Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c91e5370706c1fbc7639bd3e4c15149 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C219-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C219-28 |
filingDate |
2010-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_350e92faf0af6fc5cc2adf5b9ba25d97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a7c5136d460f3c9ed33b456cda40559 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f73aa2df6bec351e9f76263a9367061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16f9f7b7e2723b798af7abc780d905ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c12406118eada8b2f3fe57eae38ab827 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05f102596d8a8330165574c6ca519165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_913b6c38a793a83aafd4a5875e278f76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f1acf00b0a3ab1390a412dd3a0561f1 |
publicationDate |
2012-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2459520-A1 |
titleOfInvention |
Crystalline forms of fesoterodine fumarate and fesoterodine base |
abstract |
Polymorphically pure crystalline forms of fesoterodine fumarate and fesoterodine base are described and characterized. |
priorityDate |
2009-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |